Drugs for Tuberculosis
Tuberculosis (TB) is still a common cause of death
worldwide, and the prevalence of drug-resistant TB
poses challenges to its treatment and control.
Guidelines with detailed management recommendations
are available from the American Thoracic
Society, Centers for Disease Control and Prevention
(CDC) and Infectious Diseases Society of America
(IDSA)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to Treatment Guidelines from The Medical Letter, please login or register to view it online.
If you have already purchased this article, or have a subscription to Treatment Guidelines from The Medical Letter, please login or register to view it online.
Information about the article:
Title: Drugs for Tuberculosis
Publication: Treatment Guidelines from The Medical Letter
Issue #: 116
Article Code: 116a
Date: April 1, 2012
Volume: 10
Pages: 29-36
Publication: Treatment Guidelines from The Medical Letter
Issue #: 116
Article Code: 116a
Date: April 1, 2012
Volume: 10
Pages: 29-36
Subscribe to Treatment Guidelines from The Medical Letter for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)
